San Diego, CA, United States of America

Thomas Royce

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 245(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Thomas Royce: Innovator in Genetic Technologies

Introduction

Thomas Royce is a prominent inventor based in San Diego, California. He has made significant contributions to the field of genetic technologies, holding a total of six patents. His work focuses on advancing methods for analyzing target nucleic acids and improving HLA typing techniques.

Latest Patents

Among his latest patents, Royce has developed innovative methods for linking sequence reads using paired code tags. This technology involves artificial transposon sequences that contain code tags and target nucleic acids. Additionally, he has created methods for making artificial transposons and utilizing their properties to analyze target nucleic acids. Another notable patent involves HLA typing using selective amplification and sequencing, which presents methods and compositions for determining haplotypes in a sample. These methods are particularly useful for obtaining sequence information regarding HLA type and haplotype.

Career Highlights

Royce is currently employed at Illumina Corporation, a leading company in the field of genomics. His work at Illumina has allowed him to contribute to groundbreaking advancements in genetic research and technology.

Collaborations

Throughout his career, Thomas Royce has collaborated with notable colleagues, including Frank J. Steemers and Kevin L. Gunderson. These collaborations have further enhanced his research and innovation in the field.

Conclusion

Thomas Royce is a distinguished inventor whose work in genetic technologies has led to significant advancements in the analysis of nucleic acids and HLA typing. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…